The role of rotational thromboelastometry during the COVID-19 pandemic: a narrative review

Klaus Görlinger1,2, Hawra Almutawah3, Fatimah Almutawaa3

  • 1Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Insights

Rotational thromboelastometry (ROTEM®) aids in detecting COVID-19 coagulopathy, offering a comprehensive view beyond standard tests. Combining ROTEM® with standard coagulation tests improves patient monitoring and treatment guidance for better outcomes.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 is a global health crisis linked to hypercoagulability and fatal thromboembolic events.
  • Standard coagulation tests (SCT) often fail to detect COVID-19-associated hypercoagulability.
  • Viscoelastic tests like ROTEM® offer a more comprehensive assessment of coagulation status.

Purpose of the Study:

  • To review the role of rotational thromboelastometry (ROTEM®) in managing COVID-19-associated coagulopathy.
  • To explore how ROTEM® parameters can characterize coagulation abnormalities in COVID-19 patients.
  • To assess the utility of ROTEM® in guiding anticoagulant therapy and improving patient outcomes.

Main Methods:

  • Review of published literature on ROTEM® and COVID-19 coagulopathy.
  • Analysis of ROTEM® parameters in relation to hypercoagulability and hypocoagulability.
  • Comparison of ROTEM® with standard coagulation tests (SCT) for COVID-19 patients.

Main Results:

  • COVID-19 coagulopathy, assessed by ROTEM®, can range from hypercoagulability to hypocoagulability.
  • ROTEM® provides detailed information on individual coagulation status and dynamic changes.
  • Combining ROTEM® with SCT (e.g., fibrinogen, D-dimer) aids in detecting hemostasis issues.

Conclusions:

  • A multimodal diagnostic approach using ROTEM® and SCT is recommended for COVID-19 patients.
  • ROTEM® aids in guiding anticoagulant therapy and potentially improving outcomes.
  • Further research is needed to establish evidence-based guidelines for ROTEM® use in COVID-19.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
118
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
125
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
268
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
227
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
123